IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
A microRNA signature that correlates with cognition and is a target against cognitive decline | EMBO Molecular Medicine
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML
Blood Pressure and Risks of Cognitive Impairment and Dementia | Hypertension
Rapidly progressive dementias — aetiologies, diagnosis and management | Nature Reviews Neurology
Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease - Medical Clinics
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology
Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect
PDF) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease | Rosanna Squitti - Academia.edu
Chronic Kidney Disease: Cognitive Dysfunction in Chronic Kidney Disease - Renal and Urology News
The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
Evaluation of Suspected Dementia | AAFP
PDF) Mild cognitive impairment (part 1): Clinical characteristics and predictors of dementia | ResearchGate
C-reactive protein and risk of cognitive decline: The REGARDS study | PLOS ONE
Frontiers | Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - ScienceDirect
A Clinical Approach to Mild Cognitive Impairment | American Journal of Psychiatry
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text
EEG and Cognitive Biomarkers Based Mild Cognitive Impairment Diagnosis - ScienceDirect
Initial Evaluation of the Patient with Suspected Dementia | AAFP
Plasma proteomic signatures predict dementia and cognitive impairment - Tanaka - 2020 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Vascular cognitive impairment | Nature Reviews Disease Primers
Identifying and validating biomarkers for Alzheimer's disease - ScienceDirect
Cognitive Disorder Diagnosis & Treatments | Mount Sinai - New York
